Anti-Plasmodium vivax Duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon

被引:38
作者
Ceravolo, IP
Bruña-Romero, O
Braga, EM
Fontes, CJF
Brito, CFA
Souza, JM
Krettli, AU
Adams, JH
Carvalho, LH
机构
[1] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Malaria, BR-30190002 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil
[3] Univ Fed Mato Grosso, BR-78070150 Cuiaba, MT, Brazil
[4] Inst Evandro Chagas, BR-66090000 Belem, Para, Brazil
[5] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA
关键词
D O I
10.4269/ajtmh.2005.72.675
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Plasmodium vivax Duffy binding protein (DBP) is functionally important in the erythrocyte invasion process and provides a logical target for vaccine-mediated immunity. In the current study, we demonstrated that DBP is naturally immunogenic in different populations of the Brazilian Amazon, and the proportions of DBP IgG positive subjects increased with exposure to malaria, reaching a peak in those subjects with long-term exposure (> 15 years) in the Amazon area. This profile of antibody response was significantly different from the one observed for the P. viva-V merozoite surface protein 1 (MSPI19), which was relatively uniform in areas with markedly different levels of malaria transmission. In a small sample of adults with symptomless P. vivax infection, we could not detect any significant correlation between antibodies against these P. vivax proteins and asymptomatic infection. Our study provided an additional insight by demonstrating cumulative exposure as a determinant that acts independently of host age in generation of anti-DBP IgG response.
引用
收藏
页码:675 / 681
页数:7
相关论文
共 35 条
[21]   Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P-vivax ligand required for blood-stage infection [J].
Michon, P ;
Woolley, I ;
Wood, EM ;
Kastens, W ;
Zimmerman, PA ;
Adams, JH .
FEBS LETTERS, 2001, 495 (1-2) :111-114
[22]   Serologic responses to recombinant Plasmodium vivax Duffy binding protein in a Colombian village [J].
Michon, PA ;
Arevalo-Herrera, M ;
Fraser, T ;
Herrera, S ;
Adams, JH .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 59 (04) :597-599
[23]  
Miller L H, 1979, Prog Clin Biol Res, V30, P497
[24]   RESISTANCE FACTOR TO PLASMODIUM-VIVAX IN BLACKS - DUFFY-BLOOD-GROUP GENOTYPE, FYFY [J].
MILLER, LH ;
MASON, SJ ;
CLYDE, DF ;
MCGINNISS, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (06) :302-304
[25]   Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in Korea [J].
Park, JW ;
Moon, SH ;
Yeom, JS ;
Lim, KJ ;
Sohn, MJ ;
Jung, WC ;
Cho, YJ ;
Jeon, KW ;
Ju, W ;
Ki, CS ;
Oh, MD ;
Choe, K .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (01) :14-20
[26]   DIMORPHISM OF THE C-TERMINUS OF THE PLASMODIUM-VIVAX MEROZOITE SURFACE PROTEIN-1 [J].
PASAY, MC ;
CHENG, Q ;
RZEPCZYK, C ;
SAUL, A .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1995, 70 (1-2) :217-219
[27]   Intragenic recombination in the 3′ portion of the merozoite surface protein 1 gene of Plasmodium vivax [J].
Putaporntip, C ;
Jongwutiwes, S ;
Seethamchai, S ;
Kanbara, H ;
Tanabe, K .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2000, 109 (02) :111-119
[28]  
Singer BH, 2001, ANN NY ACAD SCI, V954, P184
[29]   What's your poison? [J].
Smith, A .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) :5-5
[30]  
Soares IS, 1999, MOL MED, V5, P459